You should use this to join the microcapclub that was started by...

First 5 Last

Share
Profile

Follow
IronMike94

687 Posts.

138

17/09/20

19:14

Post #: 47429454
Share
Originally posted by wombat777: ↑

I was asked for an opinion elsewhere. Reposting my response here.

I’m backing RAC due to the very, very low risk profile of Bisantrene:
Was previously approved in France (1988)
historically works very well for AML. Average Complete Response of 47% in 7 trials in 80s and 90s ( a 20% complete response would easily achieve FDA approval )
In the big historic Breast Cancer trial achieved same overall survival as Doxorubicin, plus has much better safety ( Doxorubicin is the dominant chemo drug and Bisantrene has better heart safety ).
History allows short runway to approval via a small Phase II trial in US and accelerated 505(b)(2) approval pathway
Historically trialed in over 2,000 patients
46 historic trials which I estimate has an IP value of > USD $500M (cost of rerunning trials ). $ value aside, that’s immense value for optimising their clinical strategy
Incredible clinical history aside ( trials in patients), the preclinical results from 1983 are equally impressive.

In another clonogenic study of 989 human tumor samples, doxorubicin reduced tumor colony-forming units by 50% in 14% of samples, mitoxantrone had a 21% response rate, and bisantrene was effective against 31% of the samples.

Response:
Doxorubicin 14%
mitoxantrone 21%
Bisantrene 31%
Adriamycin = Doxorubicin ( the dominant drug in chemo today )

This is preclinical performance for various cancers.

View attachment 2489024

Recent preclinical findings by City of Hope now also give Bisantrene Keytruda style potential ( that’s the biggest selling cancer drug in the world ). Places Bisantrene firmly in the immunoncology space. Works at high dose as a cancer killer and new findings show it works at low dose as a cancer inhibitor.

So a drug, previously approved, previously very successful in clinical trials is going up for approval in the next year or 2 ( IND is well-advanced ).

All that happened was that a chain of corporate takeovers in 1990s lead to drug being forgotten. The owners had financial problems and couldn’t afford to progress it ( had other priorities). Then it was forgotten.

New patents secured, FDA orphan drug designation and now new management has turned it around.

RAC was a hidden gem on the ASX until a successful investor who happens to run a DNA sequencing firm ( and knows something about cancer from his PHD ) went from A to Z through every ASX biotech and got to RAC and was stunned by what he found. He cornerstoned a placement and then joined the company and has been instrumental in turning it around.

Expand

You should use this to join the microcapclub that was started by Ian Cassel - they invest in the asx too, so could attract some new investors.
RAC Price at posting: 78.0¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

Unemployment expectations correctly called today's 4.3% rate

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

GDM

Great Divide 'rapidly evolving' into commercial miner with first Challenger pour

BRU

Buru sinks -8% on adjusted Rafael Gas Project timeline aimed to 'reduce risk'

ASX Market Close: Pretty boring day, but we're back in the 8,600s

There are more pages in this discussion • 222 more messages in this thread...

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.15		Change -0.015(1.29%)		Mkt cap ! $198.9M

Open	High	Low	Value	Volume
$1.16	$1.16	$1.14	$42.18K	36.75K

Buyers (Bids)

No.	Vol.	Price($)
1	2468	$1.15

Sellers (Offers)

Price($)	Vol.	No.
$1.16	16	1

View Market Depth

No.	Vol.	Price($)
1	2468	1.150
1	195	1.145
4	6380	1.140
3	19786	1.130
3	6677	1.125

Price($)	Vol.	No.
1.155	16	1
1.160	12640	1
1.180	1775	1
1.185	4359	2
1.195	1855	2

Last trade - 15.30pm 17/07/2025 (20 minute delay)

RAC (ASX) Chart

You should use this to join the microcapclub that was started by...

Unemployment expectations correctly called today's 4.3% rate

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Great Divide 'rapidly evolving' into commercial miner with first Challenger pour

Buru sinks -8% on adjusted Rafael Gas Project timeline aimed to 'reduce risk'

ASX Market Close: Pretty boring day, but we're back in the 8,600s

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

You should use this to join the microcapclub that was started by...

Top Stories

Unemployment expectations correctly called today's 4.3% rate

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

Great Divide 'rapidly evolving' into commercial miner with first Challenger pour

Buru sinks -8% on adjusted Rafael Gas Project timeline aimed to 'reduce risk'

ASX Market Close: Pretty boring day, but we're back in the 8,600s

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News